-
FDA advisers vote against experimental ALS therapy pushed by patients
In the last year, the FDA has approved two new drugs for ALS, after a nearly 20-year drought of new options. The approvals followed intense lobbying by advocacy groups
-
FDA skeptical of experimental ALS treatment pushed by patient advocates
NurOwn, a stem cell therapy, is at the center of a yearslong lobbying campaign by patients seeking access to experimental medicines. FDA regulators say the treatment hasn’t been shown to work.
-
‘Killing Me Softly' Singer Roberta Flack Has ALS and Can No Longer Sing, Rep Says
A representative for Roberta Flack has announced that the legendary musician has ALS, commonly known as Lou Gehrig’s disease, and can no longer sing.
-
NIH to Fund Unproven ALS Drugs Under Patient-Backed Law
The U.S. government will soon spend $25 million to help patients access experimental drugs for the incurable illness known as Lou Gehrig’s disease.
-
Despite Questionable Data, Drug for Lou Gehrig's Disease Wins FDA Approval
A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.